Malamut Richard

DirectorPelthos Therapeutics Inc. (PTHS) · full profile →Form 4 · filed Apr 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$12K
Net Open-Market Flow
-$12K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 2, 2026Sell(S)310$20.51$6K28K
Apr 2, 2026Sell(S)280$21.36$6K27K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001919246-26-000055) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.